Earnings · US stocks

Arcutis Biotherapeutics Inc (ARQT) earnings

Arcutis Biotherapeutics Inc published its quarterly report on 2026-11-04: net profit +0.00% year on year. The stock moved -23.05% in the 3 trading days after the report.

Report
quarterly report
Published
2026-11-04
Net profit YoY
+0.00%
Result
Neutral
Open earnings in Wave Radar

Stock move after the report

Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.

AfterReturnvs index
1 day-20.70%—
3 days-23.05%—
7 days-17.00%—

Report history

Over the last 8 reports, EPS beat the consensus estimate in 6 of them. The stock rose in the 3 trading days after 2 of 8 reports (average -2.74%).

PublishedEPS YoYEPSEPS surprise3 days after30 days after30d vs index
2026-11-04+0.00%0.06-64.36%-23.05%——
2026-08-05—0.11+120.00%-4.35%-2.36%-1.43%
2026-05-06—-0.09-55.17%-12.12%+8.44%+6.68%
2026-02-25—0.13+46.78%-8.33%-9.03%-7.12%
2025-10-28—0.06+163.63%+26.88%+51.53%+51.85%
2025-08-06—-0.13+17.89%-7.62%+15.30%+10.64%
2025-05-06—-0.20+4.76%-5.52%-4.54%-11.45%
2025-02-25—-0.09+65.95%+12.21%+8.93%+25.39%

The last 8 reported quarters. Moves count trading days from the first tradeable session after the report; "30d vs index" is the excess return over the market index.

Stock valuations: ARQT

How to read this

Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.

Figures are generated automatically from Wave Radar's published market data and refresh after each market close.